Cargando…
Preventive Pap-smears: balancing costs, risks and benefits.
The pattern of spontaneous screening for cervical cancer by general practitioners and gynaecologists in The Netherlands is compared with an efficient screening policy resulting from a cost-effective study. Spontaneous screening tends to start and stop too early in a woman's life, and leaves too...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977773/ https://www.ncbi.nlm.nih.gov/pubmed/1616867 |
_version_ | 1782135334041026560 |
---|---|
author | van Ballegooijen, M. Habbema, J. D. van Oortmarssen, G. J. Koopmanschap, M. A. Lubbe, J. T. van Agt, H. M. |
author_facet | van Ballegooijen, M. Habbema, J. D. van Oortmarssen, G. J. Koopmanschap, M. A. Lubbe, J. T. van Agt, H. M. |
author_sort | van Ballegooijen, M. |
collection | PubMed |
description | The pattern of spontaneous screening for cervical cancer by general practitioners and gynaecologists in The Netherlands is compared with an efficient screening policy resulting from a cost-effective study. Spontaneous screening tends to start and stop too early in a woman's life, and leaves too many women overscreened or unprotected. The combination in young age of a low incidence of invasive cancer and a high incidence of regressive lesions explains relative ineffectiveness and harmfulness of present screening practice. When screening would take place between ages 30 and at least 60, with intervals of about 5 years, as many lives could be saved for half the costs and with only 60% of the unnecessary referrals and treatments. Much attention should be paid to the coverage of the target population. Therapeutic follow-up policies for dysplastic lesions should be restrained. |
format | Text |
id | pubmed-1977773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1992 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19777732009-09-10 Preventive Pap-smears: balancing costs, risks and benefits. van Ballegooijen, M. Habbema, J. D. van Oortmarssen, G. J. Koopmanschap, M. A. Lubbe, J. T. van Agt, H. M. Br J Cancer Research Article The pattern of spontaneous screening for cervical cancer by general practitioners and gynaecologists in The Netherlands is compared with an efficient screening policy resulting from a cost-effective study. Spontaneous screening tends to start and stop too early in a woman's life, and leaves too many women overscreened or unprotected. The combination in young age of a low incidence of invasive cancer and a high incidence of regressive lesions explains relative ineffectiveness and harmfulness of present screening practice. When screening would take place between ages 30 and at least 60, with intervals of about 5 years, as many lives could be saved for half the costs and with only 60% of the unnecessary referrals and treatments. Much attention should be paid to the coverage of the target population. Therapeutic follow-up policies for dysplastic lesions should be restrained. Nature Publishing Group 1992-06 /pmc/articles/PMC1977773/ /pubmed/1616867 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article van Ballegooijen, M. Habbema, J. D. van Oortmarssen, G. J. Koopmanschap, M. A. Lubbe, J. T. van Agt, H. M. Preventive Pap-smears: balancing costs, risks and benefits. |
title | Preventive Pap-smears: balancing costs, risks and benefits. |
title_full | Preventive Pap-smears: balancing costs, risks and benefits. |
title_fullStr | Preventive Pap-smears: balancing costs, risks and benefits. |
title_full_unstemmed | Preventive Pap-smears: balancing costs, risks and benefits. |
title_short | Preventive Pap-smears: balancing costs, risks and benefits. |
title_sort | preventive pap-smears: balancing costs, risks and benefits. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977773/ https://www.ncbi.nlm.nih.gov/pubmed/1616867 |
work_keys_str_mv | AT vanballegooijenm preventivepapsmearsbalancingcostsrisksandbenefits AT habbemajd preventivepapsmearsbalancingcostsrisksandbenefits AT vanoortmarssengj preventivepapsmearsbalancingcostsrisksandbenefits AT koopmanschapma preventivepapsmearsbalancingcostsrisksandbenefits AT lubbejt preventivepapsmearsbalancingcostsrisksandbenefits AT vanagthm preventivepapsmearsbalancingcostsrisksandbenefits |